Navigation Links
Contrast-enhanced ultrasound monitors aortic aneurysm treatment

OAK BROOK, Ill. Contrast-enhanced ultrasound is an effective, noninvasive method for monitoring patients who undergo endovascular repair for abdominal aortic aneurysms, according to a new study published in the journal Radiology.

"Our findings support the addition of contrast-enhanced ultrasound as a complementary tool in the follow-up of these patients," said Rosa Gilabert, M.D., Ph.D., from the Hospital Clinic at the University of Barcelona in Spain.

An abdominal aortic aneurysm occurs when the large blood vessel that supplies blood to the abdomen, pelvis and legs becomes abnormally large or balloons outward. Abdominal aortic aneurysms can occur in anyone, but are most commonly found in men over the age of 60 with one or more risk factors, such as smoking, high blood pressure, a positive family history, high cholesterol, peripheral vascular disease or obesity. The aneurysm places stress on the wall of the aorta that can lead to wall rupture. Mortality rates after rupture are high.

Endovascular repair of abdominal aortic aneurysms (EVAR) involves placement of a stent graft called an endograft into the vessel to bypass the area of the aorta weakened by the aneurysm and keep it from rupturing. EVAR has substantially reduced mortality around the time of surgery when compared with open repair. However, EVAR effectiveness can be compromised by a complication, known as an endoleak, which carries the subsequent risk of rupture of the aneurysm sac.

Routine surveillance of endovascular stent placement with computed tomography (CT) angiography enables detection of potential complications in patients with endografts, but it also exposes the patient to ionizing radiation and potential kidney damage from the CT contrast agent.

Dr. Gilabert and colleagues studied ultrasound with a second-generation contrast agent and contrast-specific software as an alternative to CT angiography. The newer contrast agent consists of a suspension of microbubbles similar in size to red blood cells. Because of their small size, the microbubbles do not pass through the cells lining the inner surface of the blood vessel walls and thus provide a pure intravascular contrast agent that allows a real time investigation over several minutes, with the visualization of the dynamic enhancement pattern in real time.

"The main advantage of contrast-enhanced ultrasound is that it offers the possibility of real-time exploration of EVAR-treated patients, without the exposure to ionizing radiation or the risk of damage to the kidneys," she said. 'To avoid the potential risk of kidney toxicity is particularly important, because impaired renal function is not uncommon in these patients."

The researchers evaluated the technique in 35 patients who underwent EVAR. The patients had CT angiography and contrast-enhanced ultrasound studies performed at one- and six-month follow-up and yearly thereafter.

A total of 126 CT angiography and contrast-enhanced ultrasound studies were performed. Contrast-enhanced ultrasound had a sensitivity of 97 percent, a specificity of 100 percent and an accuracy of 99 percent for endoleak detection. The technique enabled correct classification of 26 of 33 endoleaks and did not miss any clinically important endoleak.

"These results support that contrast-enhanced ultrasound can be integrated in the EVAR follow-up," Dr. Gilabert said.

Contact: Linda Brooks
Radiological Society of North America

Related medicine news :

1. Contrast-enhanced MRI could play a key role in differentiating between common types of arthritis
2. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
3. Sonitor Technologies Announces New Staff Tag and Battery Powered Ultrasound Receiver
4. Groundbreaking Study Using Ultrasound for the Treatment of Intracerebral and Intraventricular Hemorrhage Stroke Shows Promise
5. Office-based ultrasound-guided FNA superior in diagnosing head and neck lesions
6. Why do physicians order costly CTs? Ultrasound yields better diagnosis, safer, less costly
7. Medical Ultrasound Now Used in New, Non-surgical Cosmetic Procedure
8. Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound
9. Johns Hopkins Health System Acquires Imorgon Ultrasound PACS Product
10. Doctors use ultrasound to diagnose possible muscular trauma in professional athletes on-site
11. MedCorp LLC Unveils New Marketing Campaign Including Refreshed Logo and All-New Website Focused on Ultrasound
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon ... programs, launches new Wimbledon Athletics Facebook page to educate the public, ... unsuspected cardiac abnormalities. About 2,000 people under the age of 25 die from ...
(Date:11/25/2015)... ... 25, 2015 , ... Smiles by Stevens is pleased to announce ... wrinkling. While many patients are aware of the benefits of Botox® in the treatment ... those suffering with discomfort, soreness, and pain as a result of Jaw Tension, TMJ ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... decades of music, friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled ... 5-6. , For 65 years, Brillianteen has been a treasured tradition ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... I found that regular bras were incredibly uncomfortable," said an inventor from Bronx, ... bra." , She developed the patent-pending RECOVERY BRA for added comfort and support. ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or ... today that the first patient has been enrolled in ... treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... 1/2 clinical trial, ESSA intends to demonstrate the safety, ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
Breaking Medicine Technology: